Does intravenous immunoglobulin (IVIG) improve outcomes in children and adults with presumed viral myocarditis?
This review updates the evidence regarding the use of intravenous immunoglobulin (IVIG) for presumed viral myocarditis in children and adults.
This is an update of a previous review. Case reports and case series have described dramatic responses to intravenous immunoglobulin (IVIG) in people with presumed viral myocarditis, and its administration has become commonplace.
Robinson et al. (Wed,) studied this question.